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A s OF MARCH 31. 1994. there were 34.493 patients on the United Network for Organ Sharing (UNOS) 
waiting list. I up from 13.115 in December 31. 1987. an 
increase of 263%. Of these. 3264 awaited liver transplanta-
tion (OLT). up from 449 in 1987 (7'27% increase). The 
supply of organ donors. on the other hand. underwent a 
marginal increase between 1988 and 1990 (from 4085 to 
4514), and has remained relatively stable since (4531 in 
1991. 4521 in 1992, and 4849 in 1993). Consequently, 
although the need has increased dramatically, we observe 
with mounting concern the persistent wastage of available 
organs and the death of potential recipients. 
Many routes have been explored in an attempt to remedy 
this situation. including the development of artificial or-
gans.2 utilization of living donors. even for extrarenal 
organs. J xenotransplantation. -1.5 and non-heartbeating do-
nors. h •7 However. a more immediate impact 011 organ 
shortage could be effected by changing the current donor 
selection criteria to include the so-called marginal donors 
(ie, obese or older living donors). 
MATERIALS AND METHODS 
The case material consists of 462 adult OLT: 54 from donors 
between 60 and 79 years old (group I) and 408 from donors 
younger than 60 years (group II). All grafts were Hushed with 
University of Wisconsin (UW) solution. Groups I and II were 
compared in terms of donors who were on pressors (defined as 
dopamine infusion > 10 ILgtkg/min or a continuous infusion of 
epinephrine or norepinephrine). pitressin. or who required cardio-
pulmonary resuscitation (CPR) before procurement. They were 
also analvzed in terms of length of stay in the intensive care unit 
(ICU). aspartate aminotransferase (AST). alanine aminotransfer-
;os.: (AL T). ischemia time. mean recipient age. and recipient UNOS 
,tatus \ UNOS status is a measure of seventy of disease. according 
to UNOS candidate classification: status I. patient may wait at 
home: status 2. patient may wait at home but needs medical 
support: status 3. patient needs to be in the hospital: status 4. 
patient requires life support). 
Continuous data are presented as the mean ::: SEM and 
categorical data as rates. Means were compared using a two· tailed 
( test and rates were compared using Pearson's chi-square lest. 
Survival analysis was performed USing the method of Kaplan-
Meier. The Significance level was set at P < .U5. 
RESULTS 
Mean donor age for group I was 65.2:: 0.6 (range 60 to 79) 
vs 35.9 :': 0.7 (range 7 to 59) for group II. In group 1 there 
were 29 donors between 00 and 64. 17 between 65 and 69. 
and ~ hetween 70 and 79. There was no difference in the 
number of donors who were on pressors. pitressin. or who 
required CPR prior to procurement. The two groups were 
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Table 1. Comparison of the Two Groups (Donor Age 2:60 
Years and <60 Years} for Various Donor Selection Criteria 
Group I Group II 
Donor Data (n = 54) (n = 408) Significance 
Pressors (%} 35.8% 40.8% NS 
Pitressin (%) 22.6% 32.2% NS 
CPR (%) 11.3% 17.9% NS 
ICU length of stay (d) 3.1 :!: 0.4 3.6:!: 0.3 NS 
ALT (U/L) 36:!: 3.5 52:!: 3.3 P = .001 
AST (UIL) 53:!: 5.5 77:!: 4.2 P = .001 
Ischemia time (h) 12.8:!: 0.6 13.4 :!: 0.2 NS 
Mean recipient age (y) 53.8 ::: 1.4 50.6 :!: 0.6 NS 
Recipient UNOS status 
Status 2 16.7% 14.7% NS 
Status 3 40.7% 42.9% NS 
Status 4 42.6% 42.4% NS 
CPR = cardiopulmonary resuscitation. ICU = intenSive care unit. ALT = 
alanine aminotransferase. AST = aspartate aminotransferase. UNOS = see 
text. 
Note. Group I donors are 60 years or older in age. Group II donors are 
younger than age 60 years. 
also comparable when evaluated for ICU length of stay, 
AST, ALT. ischemia time, mean recipient age, and recipi-
ent UNOS status (Table I). 
The 2-year actuarial graft survival rate was 43% in group 
I and 71 % in group II, a difference that is highly significant 
(P = 0.0001). The 2-year actuarial patient survival rate was 
62% in group I and 78% in group II (P = .037). Analysis of 
the causes of failure in both groups showed the following: 
1. Ischemic injury: 52% in group I and 22% in group II. 
") Sepsis: 16% in group I and 30.3% in group II. 
3. Technical reasons: ~% in group I and 9.2% in group 
II. 
4. Rejection: il% in group I and 7.3% in group II. 
5. Cardiovascular complications: 0% in group I and il.Y; 
in group II. 
6. Hepatitis: 0% in group I and 5.5% in group II. 
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7. Other: 16% in group I and 17.41,:;' in group II. 
Although half of the failures in group I were due to 
ischemic injury. the overall difference across all categories 
did not reach statistical significance (P = .07). 
DISCUSSION 
The evaluation of every single potential donor based on 
physiologic and biochemical data. instead of preset rigid 
criteria. allows an expansion of the organ donor pool. 
Patients with cardiac arrest and prolonged CPR have been 
found acceptable by post-CPR physiologic and biochemical 
criteria. and their organs have been successfully transplant-
ed.!! 
The donor age deserves special mention because. when 
assessing for specific organ donation. chronological age is 
less important than the physiologic age. The liver seems. in 
a certain way, to be protected from aging. Its great func-
tional reserve. regenerative capacity. and large blood supply 
are the key factors in delaying aging of the liver compared 
with other organs.'} Based on a positive preliminary clinical 
experience. Io we have been routinely using grafts from 
older donors. 
However. our results show that. although older donor 
livers can be used to face the present organ shortage. they 
do not function as well as livers from younger donors. and 
their use should probably be limited to selected recipients 
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(ie. those in urgent need of OL T). Retransplantation 
should be considered early when an older donor liver fails 
to function promptly. considering the high number of 
primary nonfunctions and severe ischemic injuries in group 
I patients. 
In conclusion. we believe that. given the current organ 
shortage crisis. it is mandatory to continue to use older 
donors. Unfortunately. we still cannot accurately identify 
preoperatively those grafts that are more likely to fail. and 
further studies will be required to answer this question. 
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